COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm

Howard C. Dittrich, Gregory K. Feld, Tristram D. Bahnson, A. John Camm, Sergey Golitsyn, Amos Katz, Jason I. Koontz, Peter R. Kowey, Albert L. Waldo, Arthur M. Brown

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm'. Together they form a unique fingerprint.

Medicine & Life Sciences